Study on half effective dose of bupivacaine for subarachnold block at differeent temperature

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200059571

Enrollment

Unknown

Registered

2022-05-04

Start date

2022-06-01

Completion date

Unknown

Last updated

2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Group 1:Bupivacaine at 24 degree Celsius

Group 2:Bupivacaine at 37 degree Celsius

Eligibility

Sex/Gender

Female

Age

20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Single Full-term pregnancies; 2. Scheduled for elective cesarean delivery.

Exclusion criteria

Exclusion criteria: 1. Hypertension; 2. Preeclampsia; 3. Diabetes or gestational diabetes mellitus; 4. BMI > 35 kg/m^2; 5. Any contraindications to spinal anesthesia and allergy to study drugs.

Design outcomes

Primary

Measure	Time frame
Sensory block leve;	—

Secondary

Measure	Time frame
Blood gas analysis of cord blood;Blood pressure;Side effects;	—

Countries

China

Contacts

Public ContactXiao Fei

Jiaxing Matemal and Child Health Hospital

13706597501@163.com+86 137 0659 7501

Outcome results